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Abstract
Background: Leiomyomatosis peritonealis disseminata (LPD) is a rare disease in which multiple
smooth muscle or smooth muscle-like nodules develop subperitoneally in any part of the abdominal
cavity. No reports of multiple congenital malformations associated with LPD have been found in
the English literature.
Case presentation: A 27 year-old patient referred to our gynaecology unit for pelvic pain,
amenorrhoea, stress incontinence, chronic constipation and recurrent intestinal and urinary
infections. Multiple congenital malformations had previously been diagnosed. Most of these had
required surgical treatment in her early life: anorectal malformation with rectovestibular fistula,
ectopic right ureteral orifice, megadolichoureter and hemisacrum.
An ultrasound scan and computed tomography performed in our department showed an irregular,
polylobate, complex 20 cm mass originating from the right pelvis that reached the right
hypochondrium and the epigastrium. The patient underwent laparotomy. The three largest
abdominal-pelvic masses and multiple independent nodules within the peritoneum were
progressively removed. The histological diagnosis was of LPD.
Conclusion: The case we report is distinctive in that a rare acquired disease, LPD, coexists with
multiple congenital malformations recalling a particular subgroup of caudal regression syndrome:
the Currarino syndrome.
Background
Leiomyomatosis peritonealis disseminata (LPD), also
known as diffuse peritoneal leiomyomatosis, is a rare dis-
ease in which multiple smooth muscle or smooth muscle-
like nodules develop subperitoneally in any part of the
abdominal cavity [1]. These nodules, though histologi-
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cally benign, cannot be distinguished macroscopically
from peritoneal carcinomatosis.
The aetiology is thought to be smooth muscle metaplasia
of the subperitoneal mesenchyme [2]. About 100 docu-
mented cases were found in the English language litera-
ture; LPD patients are mainly females of reproductive age
[3], and only rarely have cases affecting men been
reported [4,5]. The condition is associated with high lev-
els of exogenous and endogenous female gonadal steroids
(e.g.  pregnancy, prolonged exposure to oral contracep-
tives and/or combined hormonal replacement therapy,
granulomatous cell tumours of the ovary) [4,6], indicat-
ing that oestrogens and progestins play an important role
in the pathogenesis of LPD as they do in leiomyomata
uteri. Most LPD cases are clinically benign, and in some
instances the lesions may partially or completely regress
[5,7]. Alternatively, LPD may progress, recur or (rarely)
undergo malignant transformation [8].
We report a case of a patient affected by LPD in whom
multiple congenital malformations recalling Currarino
syndrome (CS; OMIM 176450) were previously diag-
nosed. CS is a rare form of caudal regression syndrome
(CRS), consisting in anorectal malformation (ARM), sac-
ral bone deformity and presacral mass [9]. The gene
responsible for CS is HLXB9 [10,11], which encodes a
transcription factor and is expressed in the anterior horn
regions of the spinal cord in human embryos.
Case presentation
A 27 year-old nulliparous Caucasian female was referred
to our Gynaecology Unit with a 7-month history of pelvic
pain and amenorrhoea. She also complained of stress
incontinence, chronic constipation and recurrent intesti-
nal and urinary infections. Her previous history was char-
acterised by several congenital malformations, most of
which had required surgical treatment. Neonatally, she
had undergone anoplasty for an anorectal malformation
with a rectovestibular fistula. Two months after birth, a
laparotomy showed a hydronephrosis caused by obstruc-
tion of the ectopic right ureteral orifice, which had also
caused megadolichoureter and recurrent urinary sepsis. A
cutaneous ureterostomy was performed to improve renal
function. However, two months later, she underwent a
further laparotomy following an urography showing
decreased renal function. Right nephrectomy was per-
formed. The histological diagnosis was chronic pyelone-
phritis.
Furthermore, she had been diagnosed with right hand
thumb torsion of the metacarpal-phalangeal articulation
with hypotrophy of the tenar eminence, valgus and
hemisacrum (type IV sacral malformation) [12], and a
bladder dysfunction that was treated pharmacologically.
A standard karyotype on peripheral blood cells showed a
normal female karyotype (46 XX) with no numerical or
structural chromosomal abnormalities.
An ultrasound performed in our department showed a
complex mass originating from the right pelvis that
reached the right hypochondrium and the epigastrium.
The transverse extension was more than 20 cm. Fluid was
noted in the Douglas pouch. Computerized tomography
(CT) of the abdomen and pelvis confirmed a suspicious
irregular polylobate complex mass of 24 × 19.5 × 13.5 cm;
uterus and adnexa were not identified. Chest X-ray and CT
were negative for pleural effusion or lung metastasis.
The patient underwent laparotomy. The three largest
abdominal-pelvic masses and multiple smaller independ-
ent nodules within the peritoneum were progressively
removed (Figure 1). The three biggest masses were   cap-
sulated, predominantly solid, with cystic areas containing
clear   fluid, and had dimensions 17 × 12 × 9 cm, 11 × 5 ×
5 cm and 14  × 13 × 12 cm. These samples were frozen and
sectioned for assessment. On macroscopic examination of
the excised masses, uterus and adnexa were not identified.
The frozen sections showed a benign hypocellular tumour
with myxomatous and oedematous stroma, with occa-
sional spindle cells arranged in a storiform pattern. No
malignant histological features were found.
Histological examination of the pelvic mass exhibited
multiple smooth muscle-like nodules with low cellularity,
no cytological atypia and few mitoses (Figure 2). In some
sections of the biggest mass, cervical and endometrial epi-
thelia were detected. Immunohistochemical evaluation
Macroscopic appearance of the excised mass Figure 1
Macroscopic appearance of the excised mass. 
Resected specimen of the largest abdominal-pelvic mass (17 
× 12 × 9 cm)BMC Cancer 2006, 6:127 http://www.biomedcentral.com/1471-2407/6/127
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was strongly positive for desmin and actin (Figure 3), oes-
trogen receptor (ER) and progesterone receptor (PR) (Fig-
ure 4), but negative for cytokeratin and EMA (Epithelial
Membrane Antigen). All lymph nodes appeared to be
seats of a non-specific reactive hyperplasia. Cytological
examination of the peritoneal liquid revealed only reac-
tive mesothelial cells and foamy histiocytes.
The final diagnosis, confirmed by two independent
pathologists with expertise on smooth-muscle cell
tumours, was LPD.
Among the features typical of CS, our patient presented
only hemisacrum and anorectal malformation. These
findings suggested that the patient might have harboured
a pathological mutation in the HLXB9 gene. We therefore
performed Polymerase Chain Reaction (PCR) amplifica-
tion of the three exons, intron-exon boundaries, intron 2,
and the entire 5' and 3' untranslated regions (UTR) of the
gene. The amplified PCR products were sequenced and
analysed using a CEQ2000XL DNA Analysis System
(Beckmann Coulter, Fullerton, CA, USA). We identified
no variations with respect to the reference sequence (Gen-
Bank accession number NM 005515), except for the vari-
ant *164^65insC in the 3' UTR. This variation was also
present in pooled DNA from 10 healthy individuals, dem-
onstrating that it is a benign polymorphism.
Discussion
The aetiology of LPD is unknown, but it is thought to orig-
inate from metaplasia of submesothelial, multipotent
mesenchymal cells. The developing leiomyomatous nod-
ules probably arise from Mueller's epithelium, which is
distributed throughout the subperitoneal mesenchyme.
In cases of individual predisposition and hormonal stim-
ulation, Muellerian derivatives proliferate along lines of
myofibrous differentiation [6,13].
LPD is most common in women of reproductive age.
More than half of all patients are pregnant or taking oral
contraceptives at the time of diagnosis [14].
Quade et al. showed that LPD has molecular-genetic and
cytogenetic features suggesting that individual tumourlets
are monoclonal, with a pathogenesis similar to leiomyo-
mata uteri. In LPD, the smooth muscle cells are influenced
by oestrogens [7,15], and sex steroid receptors have been
identified in nearly all cases [16]. LPD can be associated
with other oestrogen-dependent diseases including
endometriosis, ovarian clear cell carcinoma, endometrial
carcinoma [17] and ovarian fibrothecoma [2]. Recently,
two cases of development of LPD and ovarian Brenner
tumour during tamoxifen therapy have been reported [18-
22].
Although LPD is most common in premenopausal
women, cases have been reported in postmenopausal
women using [23] or not using [13,24,25] hormone
replacement therapy (HRT). The identification of luteiniz-
ing hormone (LH) receptors in LPD nodules from a post-
menopausal woman suggests that the typical
postmenopausal increase in LH levels might affect the
pathogenesis of this condition [22].
Immunohistochemical staining for actin Figure 3
Immunohistochemical staining for actin. The immuno-
histochemical evaluation is strongly positive for actin, 250 ×.
Histological examination of the pelvic mass Figure 2
Histological examination of the pelvic mass. Micro-
scopic appearance of the mass showing low cellularity, with 
no cytological atypia and few mitoses. Hematoxylin and 
eosin, 250 ×.BMC Cancer 2006, 6:127 http://www.biomedcentral.com/1471-2407/6/127
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Recently, familial occurrence of LPD has been described,
showing an autosomal dominant model with varying
degrees of penetrance [26].
Most patients with LPD present without specific symp-
toms and many documented cases of LPD have been dis-
covered incidentally during surgery (caesarean section,
laparotomy or laparoscopy). Sometimes patients may
present with mostly non-specific symptoms, such as irreg-
ular, heavy uterine bleeding and pain or a mass in the
lower abdomen [27], discomfort, urinary frequency (due
to the effect of the mass on the bladder), gastrointestinal
bleeding and peritonitis (following erosion of LPD
implants in the bowel wall) [7,13,18,28]. Sometimes
patients experience symptoms directly related to LPD:
urosepsis secondary to obstruction of the ureters, and an
acute abdomen due to ovarian torsion [29].
Sonographic and CT findings reported in the literature
include non-specific, solid, and complex soft tissue
masses that are often large and mimic a leiomyomatous
uterus. In some cases, the masses grow in a fashion similar
to that of normal uterine parenchyma, whereas others
demonstrate heterogeneous enhancement. Diagnosis may
be confused with peritoneal carcinomatosis if the masses
are present diffusely throughout the abdomen and pelvis.
Peritoneal carcinomatosis, however, is often associated
with tumour cake, ascites and liver metastases, which have
not been reported with LPD [29].
Magnetic Resonance (MR) findings include masses simi-
lar in signal intensity to skeletal muscle or uterine paren-
chyma, and when sarcomatous transformation occurs
these are not significantly different from the features of
benign implants. If the masses are located in the pelvis
adjacent to the iliac vessels, they may be confused with
lymphadenopathy [5,14,30-33]. Moreover, some multi-
ple, pedunculated leiomyomas arising from the uterus
may mimic LPD implants. Final diagnosis relies on histo-
logical examination [34] and immunohistochemical eval-
uation.
Sometimes, LPD may recur in patients taking HRT
[13,24,25] even after hysterectomy and bilateral salpingo-
oophorectomy [23], or in patients who have undergone in
vitro fertilization [35]. Matthews and Speers reported a
patient who died after a fourth recurrence of LPD and dis-
tant metastases 10 years after hysterectomy. Each recur-
rence seems to be more likely to produce morphological
evidence of sarcoma [23].
Malignant transformation of LPD is uncommon and only
ten cases have been documented in the English literature
[8,29]. Of these, only three occurred in postmenopausal
women [29,36]. The interval between initial detection of
LPD and the development of sarcoma varies from syn-
chronous diagnosis to 8 years. In most reports of malig-
nant LPD, no history of oestrogen exposure was found.
Bekkers hypothesized that LPD without exogenous or
increased endogenous oestrogen exposure, and without
expression of ER/PR by tumour cells, may represent a dif-
ferent entity carrying a higher risk of malignant transfor-
mation [3].
On the basis of these observations, we can affirm that no
established guidelines exist regarding the management of
LPD. However, therapy needs to be individualised accord-
ing to the patient's age, hormonal and reproductive status
and symptomatology. Different drugs (gonadotropin real-
ising hormone agonist, megestrol acetate, danazol) have
been considered in some cases but with poor results. If
intestinal and bladder mass effect symptoms are promi-
nent, a surgical approach is indicated [37].
We report a case of LPD diagnosed in a young lady who
has never used oral contraceptives and was referred to our
Immunohistochemical evaluation of hormonal receptors Figure 4
Immunohistochemical evaluation of hormonal recep-
tors. The immunohistochemical evaluation is strongly posi-
tive for oestrogen receptor (A) and progesterone receptor 
(B), 100 ×.BMC Cancer 2006, 6:127 http://www.biomedcentral.com/1471-2407/6/127
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department because of pelvic pain, amenorrhoea, stress
incontinence and chronic constipation. This case is unu-
sual in the coexistence of this rare acquired condition with
multiple congenital malformations, which had been diag-
nosed in our patient during her early life. A MEDLINE
search of the English language literature revealed no
report of associations between multiple malformations
and LPD.
Most of the congenital malformations diagnosed in our
patient seem to indicate a particular subgroup of the cau-
dal regression syndrome (CRS): the Currarino syndrome
(CS). CRS is a congenital heterogeneous constellation of
caudal anomalies that include varying degrees of agenesis
of the spinal column, anorectal malformations, genitouri-
nary anomalies and pulmonary hypoplasia. The combina-
tion of hemisacrum, anorectal malformation (ARM), and
presacral mass constitutes CS [9]. The hemisacrum with
its peculiar radiological aspect ("scimitar sign") is pathog-
nomonic of CS [9,38]. The most frequent type of ARM is
the rectoperineal fistula, according to the Pena classifica-
tion [39]. The presacral tumour may be an anterior
meningocoele (68%), a benign teratoma (18%), an
enteric cyst, a dermoid cyst, a lipoma, hamartoma, or,
rarely, a leimyosarcoma [40]. Other associated anomalies
in CS include tethering of the cord, hydrocephalus, duplex
ureter, vesicoureteric reflux, hydronephrosis, neurogenic
bladder, bicornuate uterus, rectovaginal fistula, hereditary
spherocytosis, etc. [38,41].
Currarino's syndrome is phenotypically very variable. It
has been classified into three different types [38]:
- Complete: full expression, presenting with hemisacrum,
anorectal malformation and presacral mass;
- Mild: hemisacrum and only one of the other malforma-
tions (i.e. anorectal malformations or presacral mass);
- Minimal: only hemisacrum is present.
Girls are more commonly affected (80% of cases). Com-
plete CS is commonly diagnosed in the first decade of life,
whereas mild or minimal CS is diagnosed predominantly
in adults [38,42-44]. Genetically, CS is an autosomal
dominant with incomplete penetrance. The gene respon-
sible for the syndrome, HLXB9, has recently been mapped
to the terminal portion of the long arm of chromosome 7
(7q36) [10,11,45]. It encodes a transcription factor
expressed in the anterior horn regions of the spinal cord
in human embryos. Mutational studies of the HLXB9 gene
in a limited number of familial and sporadic CS patients
have shown no obvious phenotype-genotype correlation
[11,45-47].
The absence of mutations within the coding sequence of
the HLXB9 gene does not totally exclude the possibility
that our patient might represent an atypical sporadic case
of CS. First, the presence of hemisacrum, anorectal mal-
formation, long-term chronic constipation and
hydroureteronephrosis represent typical features of mild
CS. Second, in contrast to the familial form of CS, in
which almost all patients show mutations in the HLXB9
gene, mutations are much rarer in sporadic cases [45-47].
Mutations outside the coding region, partial deletions of
the gene and especially genetic heterogeneity may contrib-
ute to this phenomenon [46]. As previously reported,
some CS cases carry hemizygous deletions of HLXB9.
Since we lacked the facilities for microsatellite typing, we
cannot exclude haploinsufficiency in our patient. Moreo-
ver, other candidate genes could be involved in sporadic
CS cases; in particular, genes involved in the same path-
ways as HLXB9, such as ISL1 and LIM3, which were not
investigated here [46].
Alternatively, since previous studies excluded the involve-
ment of HLXB9 in CRS [48] and we failed to identify any
HLXB9 mutation, we might more generally consider our
patient to be a rare case of association between CRS and
LPD.
Conclusion
The case we report is distinctive in that a rare acquired dis-
ease, LPD, coexists with multiple congenital malforma-
tions recalling a particular subgroup of the caudal
regression syndrome: the Currarino syndrome (CS).
Whether this association is coincidental or the expression
of a common aetiopathogenetic mechanism remains to
be ascertained.
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